Stock data
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA) reported revenue of US$35.58M and net income of -US$17.89M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$35.58M | — | -US$12.19M | -US$17.89M | — |
| 2024 | US$7.57M | — | -US$65.92M | -US$76.58M | — |
| 2023 | US$5.12M | — | -US$65.76M | -US$67.00M | — |
| 2022 | US$9.03M | — | -US$21.30M | -US$24.49M | — |
| 2021 | US$12.00M | — | -US$30.91M | -US$35.08M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$5.86M | -US$13.15M | — |
| 2026-03-31 | US$5.02M | -US$9.68M | — |
| 2025-12-31 | US$5.09M | -US$8.07M | — |
| 2025-09-30 | US$14.34M | -US$0.27M | — |
| 2025-06-30 | US$12.70M | US$0.20M | — |
| 2025-03-31 | US$3.44M | -US$9.74M | — |
| 2024-12-31 | US$0.34M | -US$16.20M | — |
| 2024-09-30 | -US$1.78M | -US$22.86M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.